Nelson L. Michael

Emailnelson.l.michael2.civmailmil

h-index

Research activity per year

If you made any changes in Pure these will be visible here soon.

Fingerprint

Dive into the research topics where Nelson L. Michael is active. These topic labels come from the works of this person. Together they form a unique fingerprint.

1 Similar Profiles

2 Finished

Combined Immunologic Approaches to Cure HIV-1
Barouch, D. H., Mellors, J. W., Michael, N. L. & Vasan, S.
NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES, National Institute of Allergy and Infectious Diseases
14/07/16 → 30/06/21
Project: Research
The Military HIV Research Program (MHRP) Clinical Trial Unit
Robb, M. L., Ake, J. A., Gramzinski, R. A. & Michael, N. L.
National Institute of Allergy and Infectious Diseases
10/12/13 → 30/11/23
Project: Research

423 Article
27 Comment/debate
16 Review article
9 Letter
More

Ad26.COV2.S and SARS-CoV-2 spike protein ferritin nanoparticle vaccine protect against SARS-CoV-2 Omicron BA.5 challenge in macaques
Yu, J., Thomas, P. V., Sciacca, M., Wu, C., Liu, J., He, X., Miller, J., Hachmann, N. P., Surve, N., McMahan, K., Jacob-Dolan, C., Powers, O., Hall, K., Barrett, J., Hope, D., Mazurek, C. R., Murdza, T., Chang, W. C., Golub, E., Rees, P. A., & 20 othersPeterson, C. E., Hajduczki, A., Chen, W. H., Martinez, E. J., Hussin, E., Lange, C., Gong, H., Matyas, G. R., Rao, M., Suthar, M., Boursiquot, M., Cook, A., Pessaint, L., Lewis, M. G., Andersen, H., Bolton, D. L., Michael, N. L., Joyce, M. G., Modjarrad, K. & Barouch, D. H., 18 Apr 2023, In: Cell Reports Medicine. 4, 4, 101018.
Research output: Contribution to journal › Article › peer-review

Open Access
Cross-Cutting Lessons Learned During the COVID-19 Pandemic-the Walter Reed Army Institute of Research Experience
Osgood, J. M., Froude, J. W., Daye, S. P., Cabrera, O. A., Scherer, M. R., Capaldi, V. F., Michael, N. L., Moon, J. E., Lombardini, E. D., Peel, S. A., Peterson, K. P., Teyhen, D. S., Murray, C. K. & O'Connell, R. J., 4 Jan 2023, In: Military Medicine. 188, 1-2, p. 158-165 8 p.
Research output: Contribution to journal › Article › peer-review

Open Access
1 Scopus citations
Efficacy of a bivalent (D614 + B.1.351) SARS-CoV-2 recombinant protein vaccine with AS03 adjuvant in adults: a phase 3, parallel, randomised, modified double-blind, placebo-controlled trial
VAT00008 Study Team, 2023, (Accepted/In press) In: The Lancet Respiratory Medicine.
Research output: Contribution to journal › Article › peer-review
1 Scopus citations
Efficacy of a monovalent (D614) SARS-CoV-2 recombinant protein vaccine with AS03 adjuvant in adults: a phase 3, multi-country study
VAT00008 Study Team, Oct 2023, In: eClinicalMedicine. 64, 102168.
Research output: Contribution to journal › Article › peer-review

Open Access
Evolution of Antibody Responses in HIV-1 CRF01_AE Acute Infection: Founder Envelope V1V2 Impacts the Timing and Magnitude of Autologous Neutralizing Antibodies
Gift, S. K., Wieczorek, L., Sanders-Buell, E., Zemil, M., Molnar, S., Donofrio, G., Townsley, S., Chenine, A. L., Bose, M., Trinh, H. V., Barrows, B. M., Sriplienchan, S., Kitsiripornchai, S., Nitayapan, S., Eller, L. A., Rao, M., Ferrari, G., Michael, N. L., Ake, J. A., Krebs, S. J., & 3 othersRobb, M. L., Tovanabutra, S. & Polonis, V. R., Feb 2023, In: Journal of Virology. 97, 2
Research output: Contribution to journal › Article › peer-review

Open Access
1 Scopus citations

Skyline Champion Compendium - A Snapshot as of September 30, 2023
Nelson L. Michael
2/10/23
2 items of Media coverage
Press/Media
Studies from U.S. Military HIV Research Program Add New Findings in the Area of U.S. Military Research (Single-cell Transcriptomics Identifies Prothymosin & Alpha; Restriction of Hiv-1 In Vivo)
Nelson L. Michael & Julie A. Ake
11/09/23
1 item of Media coverage
Press/Media
UH Law School Instructor Says He Was Banned For Criticizing ‘Nice Racism’
Nelson L. Michael
23/08/23
1 item of Media coverage
Press/Media
Australia Patent: WALTER REED ARMY INSTITUTE OF RESEARCH, THE HENRY M. JACKSON FOUNDATION FOR THE ADVANCEMENT OF MILITARY MEDICINE File Application for 'MONOCLONAL ANTIBODIES AGAINST COROVAVIRUSES AND USES THEREOF'
Nelson L. Michael
14/07/23
1 item of Media coverage
Press/Media
Reports Summarize Breast Cancer Study Results from University of Illinois Urbana-Champaign (G0S2 promotes antiestrogenic and pro-migratory responses in ER+ and ER- breast cancer cells)
Nelson L. Michael
6/07/23
1 item of Media coverage
Press/Media

Nelson L. Michael

Fingerprint

Collaborations and top research areas from the last five years

Dive into details

Combined Immunologic Approaches to Cure HIV-1

The Military HIV Research Program (MHRP) Clinical Trial Unit

Ad26.COV2.S and SARS-CoV-2 spike protein ferritin nanoparticle vaccine protect against SARS-CoV-2 Omicron BA.5 challenge in macaques

Cross-Cutting Lessons Learned During the COVID-19 Pandemic-the Walter Reed Army Institute of Research Experience

Efficacy of a bivalent (D614 + B.1.351) SARS-CoV-2 recombinant protein vaccine with AS03 adjuvant in adults: a phase 3, parallel, randomised, modified double-blind, placebo-controlled trial

Efficacy of a monovalent (D614) SARS-CoV-2 recombinant protein vaccine with AS03 adjuvant in adults: a phase 3, multi-country study

Evolution of Antibody Responses in HIV-1 CRF01_AE Acute Infection: Founder Envelope V1V2 Impacts the Timing and Magnitude of Autologous Neutralizing Antibodies

Skyline Champion Compendium - A Snapshot as of September 30, 2023

Studies from U.S. Military HIV Research Program Add New Findings in the Area of U.S. Military Research (Single-cell Transcriptomics Identifies Prothymosin & Alpha; Restriction of Hiv-1 In Vivo)

UH Law School Instructor Says He Was Banned For Criticizing ‘Nice Racism’

Australia Patent: WALTER REED ARMY INSTITUTE OF RESEARCH, THE HENRY M. JACKSON FOUNDATION FOR THE ADVANCEMENT OF MILITARY MEDICINE File Application for 'MONOCLONAL ANTIBODIES AGAINST COROVAVIRUSES AND USES THEREOF'

Reports Summarize Breast Cancer Study Results from University of Illinois Urbana-Champaign (G0S2 promotes antiestrogenic and pro-migratory responses in ER+ and ER- breast cancer cells)

Nelson L. Michael

Fingerprint

Collaborations and top research areas from the last five years

Projects

Research output

Press/Media